Biblio

Found 10 results
Filters: Keyword is Antineoplastic Agents  [Clear All Filters]
2014
Perkins SL, Cole SW.  2014.  Ziv-aflibercept (Zaltrap) for the treatment of metastatic colorectal cancer.. Ann Pharmacother. 48(1):93-8.
2013
Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Mallam S, Cheng I, Ahn R, Breen EC, Irwin MR et al..  2013.  The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.. Brain Imaging Behav. 7(4):511-23.
Moreno-Smith M, Lee SJoo, Lu C, Nagaraja AS, He G, Rupaimoole R, Han HDong, Jennings NB, Roh J-W, Nishimura M et al..  2013.  Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.. Neoplasia. 15(5):502-10.
Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DHS, Cole SW, Irwin MR, Ancoli-Israel S, Belin TR.  2013.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.. J Natl Cancer Inst. 105(11):791-801.
Le CP, Karnezis T, Achen MG, Stacker SA, Sloan EK.  2013.  Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.. Best Pract Res Clin Anaesthesiol. 27(4):409-25.
Kaminskas LM, Ascher DB, McLeod VM, Herold MJ, Le CP, Sloan EK, Porter CJH.  2013.  PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.. J Control Release. 168(2):200-8.
2012
Cole SW, Sood AK.  2012.  Molecular pathways: beta-adrenergic signaling in cancer.. Clin Cancer Res. 18(5):1201-6.
2011
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW.  2011.  Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 29(26):3517-22.
2005
Stanton AL, Bernaards CA, Ganz PA.  2005.  The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.. J Natl Cancer Inst. 97(6):448-56.
Bower JE.  2005.  Prevalence and causes of fatigue after cancer treatment: the next generation of research.. J Clin Oncol. 23(33):8280-2.